drugset / Trial / NCT02034292
Safety Study of APD-791 With Aspirin and/or Clopidogrel
RandomizedParallel-groupQuadruple-blindScreening
Summary
Evaluating safety and PK parameter of APD-791 when co-administered with aspirin and clopidogrel.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temanogrel | Small molecule | 10 mg | — |
| Subject | Temanogrel | Small molecule | 20 mg | — |
| Subject | Temanogrel | Small molecule | 40 mg | — |
| Subject | Temanogrel | Small molecule | 60 mg | — |
| Subject | Temanogrel | Small molecule | 120 mg | — |
| Subject | Temanogrel | Small molecule | 240 mg | — |
| Subject | Temanogrel | Small molecule | 320 mg | — |
| Background | Aspirin | Small molecule | — | — |
| Background | Clopidogrel | Small molecule | — | — |